Dose intensification of vedolizumab is not effective in inducing endoscopic response in Crohn's disease patients with endoscopic primary non-response

被引：0
|
作者：
Oldenburg, L.
Baert, F.
Bossuyt, P.
Hoentjen, F.
Clasquin, E.
Molnar, T.
Loewenberg, M.
Vermeire, S.
D'Haens, G.
机构：
[1] Univ Amsterdam, Med Ctr, Gastroenterol, Amsterdam, Netherlands
[2] AZ Delta, Gastroenterol, Roeselare, Belgium
[3] Imelda Gen Hosp, Gastroenterol, Bonheiden, Belgium
[4] Univ Alberta, Gastroenterol, Edmonton, AB, Canada
[5] Univ Szeged, Internal Med, Szeged, Hungary
[6] Univ Hosp Leuven, Gastroenterol, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0009
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP09
引用
收藏
页码：i17 / i18
页数：2
相关论文
共 50 条
  • [31] Serum Biomarkers Are Associated With Endoscopic and Clinical Outcomes in Crohn's Disease Patients Receiving Vedolizumab Therapy
    Holmer, Ariela
    Battat, Robert
    Dulai, Parambir
    Vande Casteele, Niels
    Neill, Jennifer
    Le, Helen N.
    Miralles, Ara
    Jain, Anjali
    Hester, Kelly
    Singh, Siddharth
    Rivera-Nieves, Jesus
    Sandborn, William J.
    Boland, Brigid
    Nghia Nguyen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S480 - S481
  • [32] Ustekinumab Dose Intensification Can Be Effective in Crohn's Disease Patients Not Responding to Induction
    Young, Ari
    Tsistrakis, Steven
    Rubinov, Jason
    Kohan, Elizabeth
    Hirten, Robert
    Ungaro, Ryan
    Cohen, Benjamin
    Cho, Judy
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Oikonomou, Ioannis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S350 - S351
  • [33] ENDOSCOPIC RESPONSE TO INDUCTION WITH USTEKINUMAB IN CROHN'S DISEASE: STARDUST INTERIM ANALYSIS
    Danese, Silvio
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Sloan, Sheldon
    Lahaye, Marjolein
    Ni, Lioudmila
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel R.
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2020, 158 (06) : S1193 - S1194
  • [34] Idiopathic Angioedema Associated with Crohn's Disease: Response to Vedolizumab
    Mason, Matthew
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S12 - S12
  • [35] Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
    Billioud, Vincent
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04): : 674 - 684
  • [36] Targeting mucosal healing: dose optimization of Vedolizumab in IBD patients with inadequate endoscopic response to standard dosing
    Dal Buono, A.
    Gabbiadini, R.
    Migliorisi, G.
    Solitano, V.
    Canziani, L.
    Repici, A.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 769 - 769
  • [37] Multiple Primary Crohn's Disease-Associated Strictures Had Poor Response to Endoscopic Balloon Dilation
    Lan, Nan
    Shen, Bo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S421 - S422
  • [38] INFLIXIMAB TREATMENT INTENIFICATION BASED ON ENDOSCOPIC ACTIVITY CONTRIBUTES TO CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE
    Tanaka, Akihito
    Kanmura, Shuji
    Komaki, Yuga
    Sasaki, Fumisato
    Nasu, Yuichiro
    Sameshima, Yohichi
    Nakamura, Yuichi
    Tokushige, Koichi
    Ohi, Hidehisa
    Sameshima, Yukinori
    Ido, Akio
    GASTROENTEROLOGY, 2019, 156 (03) : S39 - S40
  • [39] INFLIXIMAB TREATMENT INTENIFICATION BASED ON ENDOSCOPIC ACTIVITY CONTRIBUTES TO CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE
    Tanaka, Akihito
    Kanmura, Shuji
    Komaki, Yuga
    Sasaki, Fumisato
    Nasu, Yuichiro
    Sameshima, Yohichi
    Nakamura, Yuichi
    Tokushige, Koichi
    Ohi, Hidehisa
    Sameshima, Yukinori
    Ido, Akio
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S28 - S28
  • [40] Peripheral blood DNA methylation biomarkers accurately predict clinical- and endoscopic response to vedolizumab in a real-life cohort of Crohn's Disease patients
    Joustra, V.
    Hageman, I.
    Yim, A. Li
    Levin, E.
    Satsangi, J.
    Adams, A.
    De Jonge, W.
    Henneman, P.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I032 - I033
12345